FDA’s Social Media Rules Unveiled: Avoiding Costly Compliance Pitfalls in Drug & Device Marketing
Navigate New FDA Guidelines to Promote Safely, Responsibly, and Compliantly!
Instructor :
Carolyn Troiano
Webinar ID:
12528
Date: NOV 22, 2024 (FRI)
Start Time: 10 AM PT - 11:30 AM PT
Duration: 90 Mins.
Buy This Course in a Pack of 2 courses at 25% Discount HERE:
📊 The Compliance & Documentation Essentials Pack (Pack of 2)
“Stay Ahead in Regulatory Compliance and Document Control!”
2 Courses Included:
Why This Pack?
Equip yourself with critical knowledge in two rapidly evolving areas: social media regulation and data integrity for spreadsheet use in FDA-regulated environments. With an increasing emphasis on digital and social media data in regulatory compliance, these courses are designed to help compliance officers and documentation managers adapt to new requirements efficiently.
Target Audience: Compliance Managers, Quality Assurance Specialists, Documentation Managers
Why Buy the Pack?
-
- Cross-Cutting Compliance Insight: Address two crucial, high-impact areas of compliance in one purchase.
Buy This Course in a Pack of 2 courses at 25% Discount HERE:
📊 The Compliance & Documentation Essentials Pack (Pack of 2)
“Stay Ahead in Regulatory Compliance and Document Control!”
2 Courses Included:
Why This Pack?
Equip yourself with critical knowledge in two rapidly evolving areas: social media regulation and data integrity for spreadsheet use in FDA-regulated environments. With an increasing emphasis on digital and social media data in regulatory compliance, these courses are designed to help compliance officers and documentation managers adapt to new requirements efficiently.
Target Audience: Compliance Managers, Quality Assurance Specialists, Documentation Managers
Why Buy the Pack?
-
- Cross-Cutting Compliance Insight: Address two crucial, high-impact areas of compliance in one purchase.
- Save & Stay Compliant: Gain significant savings while ensuring that all aspects of digital and documentation regulations are met.
- Actionable Knowledge: Gain immediately applicable strategies to avoid non-compliance in social media and data documentation.
Note: Do you want to custom design your pack and choose courses of your choice? Just drop us an email at support@compliancemeet.com or call at Toll Free: +1 (888) 959-4972. We’ll be happy to help you!
Buy Both Courses at a 25% discount HERE
What will you learn
-
- Pros And Cons Of Social Media In Regulated Industries
- Creating FDA-Compliant Social Media Content For Drug And Device Marketing
- Understanding And Applying The Latest FDA Guidance Documents
- Balancing Benefit-Risk Information Within Social Media Guidelines
- Conveying Compliance Within Character Limits On Social Media
- Monitoring And Addressing Third-Party Misinformation ….
-
- Pros And Cons Of Social Media In Regulated Industries
- Creating FDA-Compliant Social Media Content For Drug And Device Marketing
- Understanding And Applying The Latest FDA Guidance Documents
- Balancing Benefit-Risk Information Within Social Media Guidelines
- Conveying Compliance Within Character Limits On Social Media
- Monitoring And Addressing Third-Party Misinformation Effectively
- Preparing For Upcoming Congressional Regulatory Actions Impacting Social Media
Course Description
In this 90-minute webinar, gain essential insights into the FDA’s latest guidance on using social media for promoting drug products and medical devices under FDA regulation.
This session is designed to help you develop effective strategies, policies, and procedures to ensure compliance in a rapidly evolving digital landscape.
Key takeaways include:
-
- Understanding the scope and limitations of FDA’s social media guidance for promotional content
- Developing compliant strategies to communicate product benefits, usage, and risks on social media
- Best practices for policy development to avoid common compliance pitfalls
- Real-world examples of how companies navigate social media marketing within FDA guidelines
This webinar is also invaluable for consultants in the tobacco and life sciences industries who are engaged in computer system implementation, validation, and compliance.
By attending, you’ll strengthen your grasp of FDA compliance for social media use, enhancing both your strategic and operational readiness.
This session offers practical, actionable advice to align your social media marketing efforts with FDA requirements, making it a must-attend for compliance and marketing professionals alike.
Enroll Now!
In this 90-minute webinar, gain essential insights into the FDA’s latest guidance on using social media for promoting drug products and medical devices under FDA regulation.
This session is designed to help you develop effective strategies, policies, and procedures to ensure compliance in a rapidly evolving digital landscape.
Key takeaways include:
-
- Understanding the scope and limitations of FDA’s social media guidance for promotional content
- Developing compliant strategies to communicate product benefits, usage, and risks on social media
- Best practices for policy development to avoid common compliance pitfalls
- Real-world examples of how companies navigate social media marketing within FDA guidelines
This webinar is also invaluable for consultants in the tobacco and life sciences industries who are engaged in computer system implementation, validation, and compliance.
By attending, you’ll strengthen your grasp of FDA compliance for social media use, enhancing both your strategic and operational readiness.
This session offers practical, actionable advice to align your social media marketing efforts with FDA requirements, making it a must-attend for compliance and marketing professionals alike.
Enroll Now!
Why you should attend
The FDA’s new social media guidelines mark a turning point in how companies can communicate about drug products and medical devices online.
For professionals in the pharmaceutical, medical device, and tobacco industries, staying compliant with these updated standards is no longer optional—it’s essential to protect your organization from costly regulatory repercussions.
This 90-minute webinar will empower you to understand and apply the latest FDA guidelines to your social media strategy, ensuring that your content meets regulatory standards without compromising effectiveness. The skills and insights gained in this session will directly impact how you approach social media, helping you to:
-
- Reduce legal risks by aligning your social media practices with FDA expectations, ensuring every post, tweet, or campaign complies with regulatory demands.
- Build credibility and trust with consumers and stakeholders through transparent, compliant communication.
- Strengthen your strategic planning for social media, allowing you to confidently develop compliant content strategies and avoid pitfalls.
Beyond simply understanding compliance, this session is crucial for consultants, marketers, and regulatory professionals responsible for maintaining a secure, compliant social media presence.
With real-world examples and practical insights, you’ll leave equipped to address common challenges and make informed decisions in an environment where digital marketing meets stringent regulation.
Take charge of your social media compliance with FDA-approved best practices, safeguard your organization, and become an asset in your role with these essential skills.
Join Now!
The FDA’s new social media guidelines mark a turning point in how companies can communicate about drug products and medical devices online.
For professionals in the pharmaceutical, medical device, and tobacco industries, staying compliant with these updated standards is no longer optional—it’s essential to protect your organization from costly regulatory repercussions.
This 90-minute webinar will empower you to understand and apply the latest FDA guidelines to your social media strategy, ensuring that your content meets regulatory standards without compromising effectiveness. The skills and insights gained in this session will directly impact how you approach social media, helping you to:
-
- Reduce legal risks by aligning your social media practices with FDA expectations, ensuring every post, tweet, or campaign complies with regulatory demands.
- Build credibility and trust with consumers and stakeholders through transparent, compliant communication.
- Strengthen your strategic planning for social media, allowing you to confidently develop compliant content strategies and avoid pitfalls.
Beyond simply understanding compliance, this session is crucial for consultants, marketers, and regulatory professionals responsible for maintaining a secure, compliant social media presence.
With real-world examples and practical insights, you’ll leave equipped to address common challenges and make informed decisions in an environment where digital marketing meets stringent regulation.
Take charge of your social media compliance with FDA-approved best practices, safeguard your organization, and become an asset in your role with these essential skills.
Join Now!
Areas Covered
-
- Pros and Cons of Using Social Media Venues
Examine the advantages and potential pitfalls of social media use in regulated industries, enabling you to make informed decisions about platforms and content strategies. - Compliant Use of Social Media in an FDA-Regulated Environment
Learn how to navigate FDA guidelines to create social media content that meets compliance standards while effectively engaging your audience. - Understanding FDA Draft Guidance Documents
Gain clarity on the latest FDA draft guidance documents, including their implications for digital marketing and the steps necessary to stay compliant. - Balancing Benefit and Risk Information on Social Media
Explore techniques for presenting balanced information on product benefits and risks, a critical requirement in all FDA-regulated communications. - Managing Character Space Limitations on Social Media
Discover best practices for conveying compliant messages within character limits on platforms like Twitter, ensuring full transparency without overloading content. - Addressing Misinformation Posted by Independent Third Parties
Learn how to monitor and manage misinformation on social media, particularly when it involves third-party posts, while staying within regulatory guidelines. - Anticipating Pending Regulatory Action by the US Congress
Stay informed on upcoming regulatory changes that may impact social media use in FDA-regulated industries, ensuring your strategies are future-proof and adaptable.
- Pros and Cons of Using Social Media Venues
BONUS:
-
- PDF copy of the presentation handout for your future reference.
- Soft copy of the certificate of completion on request.
- Q&A Session with the Presenter: Get your pressing questions answered verbally, via chat or email
-
- Pros and Cons of Using Social Media Venues
Examine the advantages and potential pitfalls of social media use in regulated industries, enabling you to make informed decisions about platforms and content strategies. - Compliant Use of Social Media in an FDA-Regulated Environment
Learn how to navigate FDA guidelines to create social media content that meets compliance standards while effectively engaging your audience. - Understanding FDA Draft Guidance Documents
Gain clarity on the latest FDA draft guidance documents, including their implications for digital marketing and the steps necessary to stay compliant. - Balancing Benefit and Risk Information on Social Media
Explore techniques for presenting balanced information on product benefits and risks, a critical requirement in all FDA-regulated communications. - Managing Character Space Limitations on Social Media
Discover best practices for conveying compliant messages within character limits on platforms like Twitter, ensuring full transparency without overloading content. - Addressing Misinformation Posted by Independent Third Parties
Learn how to monitor and manage misinformation on social media, particularly when it involves third-party posts, while staying within regulatory guidelines. - Anticipating Pending Regulatory Action by the US Congress
Stay informed on upcoming regulatory changes that may impact social media use in FDA-regulated industries, ensuring your strategies are future-proof and adaptable.
- Pros and Cons of Using Social Media Venues
BONUS:
-
- PDF copy of the presentation handout for your future reference.
- Soft copy of the certificate of completion on request.
- Q&A Session with the Presenter: Get your pressing questions answered verbally, via chat or email
Who is this course for
Everybody Benefits from Watching This. Even Better When Done as a Group!
-
- Marketing Leaders Aiming to Ensure Social Media Compliance
- Regulatory Affairs Specialists Focused on Reducing Risk Exposure
- Compliance Managers Striving to Mitigate Social Media Liabilities
- Training Heads Crafting Tailored Compliance Programs for Teams
- Legal Advisors Assisting in Regulatory Compliance
- Product Managers Overseeing Digital Promotions for Regulated Products
- HR Professionals Looking to Strengthen Regulatory Training
- Social Media Managers Creating Content within FDA Guidelines
- Consultants in Life Sciences and Tobacco Industries
Everybody Benefits from Watching This. Even Better When Done as a Group!
-
- Marketing Leaders Aiming to Ensure Social Media Compliance
- Regulatory Affairs Specialists Focused on Reducing Risk Exposure
- Compliance Managers Striving to Mitigate Social Media Liabilities
- Training Heads Crafting Tailored Compliance Programs for Teams
- Legal Advisors Assisting in Regulatory Compliance
- Product Managers Overseeing Digital Promotions for Regulated Products
- HR Professionals Looking to Strengthen Regulatory Training
- Social Media Managers Creating Content within FDA Guidelines
- Consultants in Life Sciences and Tobacco Industries
Instructor Profile
Carolyn (McKillop) Troiano has more than 40 years of experience in the tobacco, pharmaceutical, medical device and other FDA-regulated industries. She has worked directly, or on a consulting basis, for many of the larger pharmaceutical and tobacco companies in the US and Europe, developing and executing compliance strategies and programs. Carolyn is currently active in the Association of Information Technology Professionals (AITP), and Project Management Institute (PMI) chapters in the Richmond, VA area.
During her career, Carolyn worked directly, or on a consulting basis, for many of the larger pharmaceutical companies in the US and Europe. She developed validation programs and strategies back in the mid-1980s, when the first FDA guidebook was published on the subject, and collaborated with FDA and other industry representatives on 21 CFR Part 11, the FDA’s electronic record/electronic signature regulation.
